A groundbreaking partnership is set to revolutionize interventional cardiology! The Society for Cardiovascular Angiography & Interventions (SCAI) and Cardiovascular Research Technologies (CRT) have joined forces, promising a new era of innovation and improved patient outcomes. This collaboration is designed to boost the field through shared educational programs, advocacy efforts, and exciting new research initiatives.
As part of this exciting venture, SCAI members will receive discounted registration for CRT 2026, where the two organizations will co-host educational sessions. Supporting their shared commitment to advocacy, SCAI will organize an annual 'Day on the Hill' legislative event, coinciding with the CRT meeting in Washington, D.C. Over the long term, the partnership will delve into collaborative research, including innovative registry and clinical trial programs.
"Collaboration is the cornerstone of progress in medicine, particularly in interventional cardiology, and SCAI is dedicated to enhancing patient outcomes," stated Dr. Srihari S. Naidu, MD, MSCAI, President of SCAI. "SCAI and CRT share a common goal: to advance interventional cardiology through collaboration, scientific advancements, advocacy, regulatory policies, and education. Despite approaching these goals from different perspectives, our new partnership reflects a growing alignment in vision, and SCAI eagerly anticipates the many benefits of working with CRT."
This partnership will be steered by the SCAI–CRT Task Force, comprised of representatives from both organizations, who will identify and coordinate collaborative opportunities. To support these initiatives, SCAI will establish a working group to evaluate research projects, including the development of registries and clinical trials, proposed by SCAI, its members, and CRT's research network. CRT will provide core lab services, and SCAI and CRT will jointly seek external funding.
But here's where it gets interesting: the collaboration aims to address the challenges facing interventional cardiology head-on. "Together, we will forge new avenues to engage physicians, foster innovation, and create programs that tackle the clinical and policy hurdles shaping our field," said Dr. J. Dawn Abbott, MD, MSCAI, Chair of the SCAI–CRT Partnership Task Force and President-elect of SCAI. "By combining our strengths, we can accelerate investigator-led research, expand professional development, and ultimately provide superior patient care."
"Through CRT's collaboration with SCAI, we're amplifying the impact of both organizations," added Dr. Ron Waksman, MD, MSCAI, Chair of the CRT meeting. "This partnership allows us to connect clinical science, advocacy, and education in ways that will fuel innovation and unite experts from across cardiovascular medicine. Our shared vision is to strengthen the research pipeline, inspire the next generation of interventionalists, and ensure that patients everywhere benefit from the rapid advancements in the interventional lab."
A key aspect of this collaboration is the focus on advocacy. This highlights the importance of influencing policy and regulations to benefit both medical professionals and patients. Do you think this emphasis on legislative activities is crucial for advancing medical progress?
This partnership promises a future where collaboration, research, and education converge to create a healthier tomorrow. What other areas of medicine do you think could benefit from similar collaborations?
